Nature Coast Clinical Research

09/09/2025

Extra, Extra..!!! FLU Season ahead! Call our Crystal River Office today at (352) 563-1865 to learn more about our new Flu Research Studies starting soon!
https://encoredocs.com/portfolio/flu-vaccine/

08/09/2025

Do you or someone you know have a Chronic Hepatitis C Virus Infection?
Qualified volunteers may receive at no cost:
↪Investigational medications
↪Study-related medical care from a qualified doctor
↪Possible compensation for time and travel
↪No health insurance is required to participate in our studies.
Call our Inverness Office to learn more (352) 341-2100
https://encoredocs.com/portfolio/hepatitis-c-treatment/?fbclid=IwY2xjawMsDCZleHRuA2FlbQIxMABicmlkETFUakFNTDZFSjFOY285OWthAR73tx6AZ-gQVBWbeElkVj8ZaJ4iLbWlh8UL_288SH_TSciPbpeZz6V_RHCicg_aem_vm1EFGLMqkWmCz90A4ltXA

05/09/2025

Ever wonder how new treatments reach patients? Clinical trials make it possible. They unfold in four key phases—each one ensuring that new therapies are safe, effective, and ready for real-world care. Swipe to explore how these phases work and why they matter.

💡 Curious about the studies we’re conducting? Learn more and see how you can get involved in shaping the future of medicine: https://hubs.li/Q03H4dg30

03/09/2025

Do you or someone you know have Chrohn’s Disease?
Qualified volunteers may receive at no cost:
-Investigational medications
-Study-related medical care from a qualified doctor
-Possible compensation for time and travel
No health insurance is required to participate in our studies.
Call us today to learn more! (352) 341-2100
https://encoredocs.com/portfolio/crohns-disease/

28/08/2025

Benefits beyond treatment!
↪ Receive extra attention from doctors and medical professionals who are invested in your safety.
↪ Receive additional monitoring to ensure your safety, including blood draws and imaging; all free of cost and no insurance necessary.
↪ Undergo treatment overseen by impartial Investigational Review Boards and the FDA.
↪ Help find new cures and treatments for future generations. You have the power to make a difference!!
https://encoredocs.com/enrolling-studies/

28/08/2025

From coast to coast, we’re making an impact! With 28 locations across the United States, Flourish Research is dedicated to advancing science and improving lives through innovative clinical studies.

Each of our locations is a hub for discovery, where participants and researchers come together to shape the future of medicine. Whether you’re looking to contribute to groundbreaking research or learn more about how clinical studies work, we’re here for you.

🔗 Learn more about our studies and how you can get involved today: https://hubs.li/Q03FVXkF0

26/08/2025

Do you or someone you know have Polycystic Kidney Disease?
Qualified volunteers may receive at no cost:
➡️Investigational medications
➡️Study-related medical care from a qualified doctor
➡️Possible compensation for time and travel
➡️No health insurance is required to participate in our studies.
https://medevidence.com/dealing-with-autosomal-dominant-polycystic-kidney-disease-adpkd

21/08/2025

Imagine being part of something that could truly shape the future of healthcare. Clinical trials aren’t just about testing new treatments — they’re about bringing hope, advancing knowledge, and potentially improving outcomes for generations to come.

Qualified participants enrolled in a study receive study-related care from experienced physicians at no cost and may be compensated for their time and travel — all while contributing to important medical discoveries. Your involvement today could help lead to better treatment options tomorrow.

Interested in learning more? Express your interest and see if a study may be right for you: https://hubs.li/Q03DRr9X0

15/08/2025

Managing obesity and type 2 diabetes is complex, but research is advancing. Orforglipron, a once-daily oral medication, is being studied as a needle-free alternative to injectable treatments. It doesn’t require refrigeration and offers a convenient option under investigation.

In a Phase 3 trial, participants taking orforglipron lost an average of 12.4% of their body weight—about 27 pounds—over 72 weeks. Researchers also observed changes in cardiovascular measures, shaping the future of treatment.

By mimicking gut hormones called GLP-1 receptor agonists, orforglipron may help promote fullness and satisfaction after meals, offering new possibilities for weight and metabolic health.

Interested in participating in a clinical trial? Learn about our latest studies here: https://hubs.li/Q03CZmZp0

05/08/2025

02/08/2025

Are you living with Idiopathic Gastroparesis? If so, you may qualify for the EnvisionGI study, currently enrolling. Call us today @ (352) 341-2100 to schedule an evaluation. https://encoredocs.com/portfolio/diabetic-gastroparesis/